Substance Name: Alemtuzumab [USAN:INN:BAN]
RN: 216503-57-0
UNII: 3A189DH42V
Note
- An anti-CD52 ANTIGEN monoclonal antibody used for the treatment of certain types of CD52-positive lymphomas (e.g., CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS T-CELL LYMPHOMA; and T-CELL LYMPHOMA). Its mode of actions include ANTIBODY-DEPENDENT CELL CYTOTOXICITY.
Molecular Formula
- Unspecified
Classification Codes
- Antineoplastic (Monoclonal Antibody)
- Antineoplastic Agents
- Antineoplastic Agents, Immunological
- Antirheumatic Agents
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Alemtuzumab
- Alemtuzumab [USAN:INN:BAN]
MeSH Heading
- Alemtuzumab
Synonyms
- Alemtuzumab
- Campath
- Campath 1H
- Campath 1H/LDP03
- Campath-1H
- HSDB 8177
- Immunoglobulin G 1 (human-rat monoclonal CAMPATH-1H gamma1-chain anti-human antigen CD52), disulfide with human-rat monoclonal CAMPATH-1H light chain, dimer. Molecular weight is approximately 150,000 daltons
- LDP-03
- Lemtrada
- UNII-3A189DH42V
Systematic Name
- Immunoglobulin G1, anti-(human CD52 (antigen)) (human-rat monoclonalCAMPATH-1H gamma1-chain), disulfide with human-rat monoclonal CAMPATH-1H light chain, dimer
Registry Numbers
CAS Registry Number
- 216503-57-0
FDA UNII
- 3A189DH42V
Other Registry Numbers
- 126775-97-1
- 478159-77-2
- 727728-72-5
System Generated Number
- 0216503570